Bodyfat & Muscle when you Stop GLP-1s?

Bodyfat and Muscle after GLP-1 Weight Loss Medications?

GLP-1 medications can enable life-transforming weight loss, but what actually happens when treatment ends? Specifically, what do we know about bodyfat & muscle after GLP-1 use and cessation?

A newly published systematic review from researchers at the University of Cambridge provides some of the clearest evidence to date. It also raises an important question that could significantly influence long-term health outcomes.

Review Overview

What Did Researchers Analyse?

The review included:

• 48 studies

• 36 randomised controlled trials

• 3,236 participants

• Follow-up periods extending up to one year after stopping GLP-1 medications

The aim was to understand what happens to body weight and cardiometabolic health once treatment is discontinued.

Key Findings?

Weight Regain Is Common

The review reported:

📈 An average of 60% of lost weight regained within one year

📈 Approximately 75% of lost weight eventually regained

📈 HbA1c and blood pressure trending back towards pre-weight loss levels

At first glance, these findings may not seem entirely negative.

After all, if someone loses a substantial amount of weight and maintains approximately 25% of that loss over the long term, there are still likely to be meaningful health benefits.

However, the researchers highlighted a potentially important concern.

The Big Outstanding Question

What Type of Weight Is Lost and Regained?

The most important issue may not be how much weight returns, but what that weight consists of.

Study lead author Budini noted:

"If the regained weight is disproportionately fat, individuals may ultimately be worse off than before in their fat-to-lean mass ratio, which may have adverse consequences for their health."

This distinction matters enormously.

If a significant proportion of the weight lost during treatment is muscle mass, and the weight regained after treatment is primarily body fat, overall body composition may deteriorate despite little change in body weight.

Why Muscle Loss Matters?

Weight Loss Is Not Always Fat Loss

Research has consistently shown that body weight is made up of multiple tissues, including:

• Body fat

• Skeletal muscle

• Bone mass

• Water and glycogen stores

Several studies suggest that approximately 40% to 60% of weight lost during GLP-1 treatment may come from lean tissue, including muscle mass.

While weight reduction often improves health outcomes, excessive muscle loss can create challenges such as:

• Reduced metabolic rate

• Lower physical function

• Increased frailty risk with ageing

• Reduced insulin sensitivity

• Greater likelihood of future weight regain

This is why body composition matters just as much as body weight.

Why GLP-1 Medications Increase the Risk?

Rapid Weight Loss Has Consequences

Rapid weight loss, regardless of the method used, generally increases the likelihood of losing lean tissue alongside fat mass.

GLP-1 medications can make substantial weight loss more achievable than ever before, which is one of their greatest strengths.

However, this also makes preserving muscle mass a crucial part of the treatment strategy.

The goal should not simply be to lose weight.

The goal should be to lose fat while maintaining as much muscle and bone mass as possible.

Practical Takeaways?

Focus on Sustainable Fat Loss

When considering GLP-1 medications, several principles are worth keeping in mind:

👉 Sustainable weight loss means prioritising fat loss rather than simply reducing body weight.

👉 Preserving muscle mass and bone density should be a primary objective throughout the weight loss process.

👉 Faster weight loss generally increases the risk of muscle loss.

👉 Resistance training and muscle-building exercise are essential tools for maintaining lean tissue.

👉 High-quality nutrition and adequate protein intake should form the foundation of any successful weight management strategy.

👉 Long-term behavioural change remains critical for maintaining results after medication discontinuation.

Building a Long-Term Strategy

Medication Is a Tool, Not the Entire Solution

GLP-1 medications can be incredibly effective and, for many individuals, genuinely life-changing.

However, they work best when combined with sustainable improvements in:

• Dietary habits

• Physical activity

• Resistance training

• Sleep quality

• Stress management

• Behavioural change

The individuals who achieve the best long-term outcomes are often those who use the medication as an opportunity to establish habits that can continue supporting health long after treatment has ended.

The Bottom Line?

This review suggests that most people regain a substantial proportion of lost weight after stopping GLP-1 medications.

However, the more important question may be what happens to body composition during that process.

If muscle mass is lost during treatment and fat mass is regained afterwards, long-term health outcomes may be less favourable than the scale alone suggests.

For this reason, preserving muscle mass should be a central goal of any weight loss strategy.

GLP-1 medications can be powerful tools, but sustainable success depends on pairing them with high-quality nutrition, resistance training and lasting lifestyle change.

When those foundations are in place, the benefits can extend far beyond the period of medication use.

---

My clients enjoy clear, specific, actionable guidance on how to use diet, supplementation, lifestyle and functional testing to reach their personal health goals and resolve their health issues.

Why not book a free health kickstart call to find out how we would enable better health for you? 📲